コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 on cancers (e.g., liver, colorectal, breast, pancreas).
2 h a 120-min dynamic PET scan centered on the pancreas.
3 abnormalities in the hepatobiliary system or pancreas.
4 including those of the breast, prostate, and pancreas.
5 always results in a lethal situation for the pancreas.
6 Tregs) and maintains immune tolerance in the pancreas.
7 intolerance and that Pg translocates to the pancreas.
8 termine drug uptake in tumors growing in the pancreas.
9 nant and malignant conditions related to the pancreas.
10 omeostatic and inflammatory processes of the pancreas.
11 polysynaptically connected to the liver and pancreas.
12 e major pancreatic ducts (MPDs) of the human pancreas.
13 relative to the same cells isolated from the pancreas.
14 MRF at 1.5 T and 3 T was demonstrated in the pancreas.
15 the cause of his symptoms and to assess the pancreas.
16 eneration/developmental studies in the human pancreas.
17 expressed no detectable CTRL protein in the pancreas.
18 ys, brain, heart, intestines, fat tissue and pancreas.
19 ive progenitor-like populations in the adult pancreas.
20 esults from destruction of beta cells in the pancreas.
21 e tumors in the liver, kidney, prostate, and pancreas.
22 and migration into lymphoid tissues and the pancreas.
23 ja1 restores beta-cell expansion in the aged pancreas.
24 adipose tissues including liver, muscle, and pancreas.
25 ue homeostasis in the neoplastic and injured pancreas.
26 y network between the endocrine and exocrine pancreas.
27 ggest MEN1 may also function in the exocrine pancreas.
28 d levels of tissue repair in the human donor pancreas.
29 gan systems including gut, liver, heart, and pancreas.
30 , such as adipose tissue, muscle, liver, and pancreas.
32 , 14.9-33.4]; 3 h: 28.2 [95%CI, 16.5-40.0]), pancreas (1 h: 42.4 [95%CI, 12.3-72.5]; 3 h: 41.1 [95%CI
33 0.3 +/- 2.2 and 22.5 +/- 1.6, respectively), pancreas (12.2 +/- 0.8 and 9.5 +/- 0.7, respectively), a
35 s (kidney 5 years: 76.5% vs 82.3%, P < 0.01; pancreas 5 years: 72.2% vs 76.3%, P = 0.01; respectively
37 rs were included: 318 (66%) kidney or kidney/pancreas, 73 (15.1%) liver, 57 (11.8%) heart, and 30 (6.
38 US cohort (kidney: 91.5% vs 87.9%, P = 0.11; pancreas: 87.4% vs 81.3%; P = 0.04, respectively) and pe
39 al-origin deconjugase (rat serum and chicken pancreas) (AE-LC-MS/MS) was used in the LC-MS/MS methods
40 -ghrelin (AG), which is also produced in the pancreas, affects beta-cell function, with particular at
42 are of the possibility of acute and cGVHD in pancreas after kidney transplant recipients and be able
43 of possible cGVHD occurring in recipients of pancreas after kidney transplantation, which were diagno
44 e digestive enzyme chymotrypsin protects the pancreas against pancreatitis by reducing harmful trypsi
48 BMP/SMAD signaling is activated in protocol pancreas allograft biopsies from recipients on tacrolimu
50 were actively followed and had a functional pancreas allograft for >25 years as of October 31, 2018.
51 oncocytic papillary neoplasms (IOPNs) of the pancreas and bile duct contain epithelial cells with num
52 macropinocytic, but not non-macropinocytic, pancreas and breast cancer cells resistant to these trea
53 mechanisms for cardiovascular malformations, pancreas and diaphragm dysgenesis that arise in patients
54 onstrated similar genetic profiles in normal pancreas and early clinical stage primary INS, whereas l
55 uding the lungs, spleen, liver, lymph nodes, pancreas and extrahepatic bile duct with potential for r
56 tch ligands play specific roles in the adult pancreas and highlight a novel function of the Delta/Not
57 cipating at the Ninth International European Pancreas and Islet Transplant Association (EPITA) Worksh
58 is the predominant neoplastic disease of the pancreas and it represents the fourth most frequent caus
59 bility in listing practices for simultaneous pancreas and kidney (SPK) transplant and define eligibil
64 e detected virus in systemic tissues such as pancreas and liver just 20 min after oral inoculation.
66 derlying these divergent T cell responses in pancreas and lung cancer are differences in infiltrating
68 iverticula are usually asymptomatic, annular pancreas and malrotation may manifest in the first decad
69 PD-L1 platelets) accumulate in the inflamed pancreas and may suppress the activity of pancreas autor
71 e differences in immune response in lung and pancreas and potential approaches to overcome immunoresi
72 expressed in human PDAC compared with normal pancreas and present on both tumor and immune cells.
76 Six cancer cell lines (breast, prostate, and pancreas) and a mouse model of the mammary tumor were em
77 changes in the trachea, large intestine, and pancreas, and abnormalities in the development of the ma
78 rder, pancreas border with tumor, nontumoral pancreas, and aorta were recorded on pancreatic parenchy
81 of multipotent progenitors in the developing pancreas, and loss of Dll1 leads to premature endocrine
83 creatic cancer tissues and cells with normal pancreas, and measured levels of CDH11 protein in human
85 rtions, we studied adenocarcinomas of colon, pancreas, and stomach, and found a variable number of so
86 angiogenesis and beta-cell expansion in the pancreas are coupled by a distinct age-dependent subset
89 ence with complex cancer operations near the pancreas are similar to PD outcomes at hospitals with hi
90 nks both endocrine and exocrine parts of the pancreas as a single organ through the integrated vascul
91 by hormone-secreting endocrine cells in the pancreas, as well as glucose utilization and production
93 gap, we investigated fetal and neonatal pig pancreas at multiple, crucial developmental stages using
94 ed pancreas and may suppress the activity of pancreas autoreactive T cells in newly hyperglycemic non
97 ons of interest in tumor core, tumor border, pancreas border with tumor, nontumoral pancreas, and aor
99 gen and more edema, infiltration of lung and pancreas by inflammatory cells, and plasma amylase activ
102 ete tumor regressions in a therapy-resistant pancreas cancer model, but only when combined with immun
103 Het to 84 tumor samples from 14 prostate and pancreas cancer patients, we identify subclonal CNAs and
104 counseling should be considered for familial pancreas cancer relatives who are eligible for surveilla
106 12: Clinicians should consider discontinuing pancreas cancer screening in high-risk individuals when
109 E 13: The limitations and potential risks of pancreas cancer screening should be discussed with patie
110 reviewed in this work is based on reports of pancreas cancer screening studies in high-risk individua
113 ding first-degree relatives of patients with pancreas cancer with at least 2 affected genetically rel
114 s with 1 or more first-degree relatives with pancreas cancer with Lynch syndrome, and mutations in BR
115 ndromes associated with an increased risk of pancreas cancer, including all patients with Peutz-Jeghe
116 uals when they are more likely to die of non-pancreas cancer-related causes due to comorbidity and/or
119 eated the first comprehensive atlas of human pancreas cells including epithelial and nonepithelial co
120 Participation in a registry or referral to a pancreas Center of Excellence should be pursued when pos
122 o American Society of Transplantation Kidney/Pancreas Community of Practice members and 202 US transp
124 of IL22 and the IL22 receptor (IL22R) in the pancreas compared with other tissues in mice; IL22 incre
125 not (111)In-IgG-TAT or (18)F-FDG, within the pancreas correlated positively with the age of KPC mice,
126 ow that the number of Pg translocated to the pancreas correlates with the number of bihormonal cells
127 with reduced levels of citrullination in the pancreas, decreased circulating autoantibody titers agai
128 in SLC26A9 expression in ductal cells of the pancreas delays the age at onset of diabetes, suggesting
129 re the requirement of O-GlcNAcylation during pancreas development and show that Ogt is essential for
130 enes, most significantly in genes related to pancreas development or function (GATA4, GATA6, PROX1, O
131 iation spanning a short time-window early in pancreas development, a phenotype we reproduced in mice.
132 Notch signaling is a major regulator of pancreas development, yet how it precisely controls panc
137 and function suggest that porcine and human pancreas developmental biology may have useful homologie
139 Salmonid alphavirus infection results in pancreas disease causing severe economic losses for Atla
144 ession clusters of four highly expressed and pancreas-enriched genes (PRSS1, PNLIP, CLPS, and/or CELA
145 aries age 65 to 99 who underwent surgery for pancreas, esophageal, lung, rectal, and colon cancer fro
146 43,007 Medicare patients underwent either pancreas, esophageal, lung, rectal, or colon resection f
149 surrounding microenvironment is pivotal for pancreas formation and differentiation as well as adult
153 isolation of younger and fibrotic pediatric pancreases, gave increased islet yield with improved pat
154 t follow up, all 39 patients with functional pancreas graft had at least one comorbidity, such as hyp
155 %, 88.9%, and 76.0%; P = .3), death-censored pancreas graft survival (CACPR: 89.3%, 82.7%, 75.0%; non
156 sociated with lower probability of prolonged pancreas graft survival (hazard ratio: 0.52; confidence
159 tional graft at last follow up and 9 (18.8%) pancreas grafts were lost due to patient death or graft
160 r inhibition of 12-LOX impairs both exocrine pancreas growth and unexpectedly, the generation of insu
161 77 liver, 286 lung, 213 heart, and 73 kidney-pancreas) had >=12 months of follow-up; 1520 patients (5
163 islet, consisting of 1-2% mass of the whole pancreas, has long been believed to be regulated indepen
168 evidence that Men1 is essential for exocrine pancreas homeostasis in response to inflammation and onc
170 ation and tumor suppression in the endocrine pancreas; however, intriguing recent data suggest MEN1 m
171 eterogeneity and cellular composition of the pancreas in neonates and adults in healthy and diseased
174 d density of leukocytes) within the exocrine pancreas in this disease, but the mechanisms underlying
175 y, hazards for specific cancers (e.g. liver, pancreas) in type 2 patients cannot be explained by obes
177 ing analyses in hereditary and idiopathic CP pancreases indicate differences in innate and adaptive i
178 Acute Pancreatitis (AP) is sudden onset pancreas inflammation that causes systemic injury with a
179 hemogenetic stimulation of beta-cells and to pancreas infusion with serotonin, but were not sensitive
182 pro-inflammatory signaling in the endocrine pancreas involves activation of NF-kappaB, which is beli
185 ral damage from inflammation in the exocrine pancreas is not a likely cause of DM in these dogs.
186 here appear to be significant differences in pancreas islet cell lipid handling between species, and
187 hypothesized that transplanting simultaneous pancreas kidney (SPK) grafts from donors with a history
188 National Institutes of Health, simultaneous pancreas-kidney (SPK) recipients were randomized to a ca
195 d be considered when there are no concerning pancreas lesions, with shortened intervals and/or the pe
196 0-day postoperative events following complex pancreas, liver, and rectal surgeries, and liver transpl
197 H&E staining revealed overt lesions in the pancreas, liver, kidney, esophagus, duodenum, and ileum
198 or types (including colon, breast, prostate, pancreas, lung adenocarcinoma, and squamous cell carcino
199 phagus, stomach, colon, rectum, anus, liver, pancreas, lung, breast, cervix uteri, and prostate) comp
200 s Cre under tissue-specific promoters of the pancreas, mammary gland and other secretory tissues, as
201 Expression of PRSS1R122H protein in the pancreas markedly increased stress signaling pathways an
202 Kazal type 1 (SPINK1) by mesotrypsin in the pancreas may contribute to the pathogenesis of pancreati
203 insulin delivery (also called an artificial pancreas) may improve glycemic outcomes in children with
207 oscillating Notch activity in the developing pancreas, modulated by Jag1, is required to coordinate M
209 lood flow between the endocrine and exocrine pancreas, not necessarily a unidirectional blood flow as
210 Moreover, immune cells infiltrating the pancreas of humans with T1D exhibited increased expressi
211 an important ferroptosis suppressor, in the pancreas of mice with cerulean- or L-arginine-induced pa
214 observed among GC Tfh cells infiltrating the pancreas of NOD mice, which was enhanced by loss of SAP
216 assessment of the pathology of the endocrine pancreas of patients with LADA and for comparison in a f
218 Patients who had colorectal, liver, and pancreas operations abstracted in 2011-2017 ACS NSQIP Pa
221 D accumulation in the intact human and mouse pancreas over a range of ages and states of diabetes.
222 gs suggest that Pg/gingipain translocates to pancreas, particularly beta-cells in both humans and mic
225 luding donor selection, pancreas processing, pancreas perfusion and digestion, islet counting and cul
227 t critical steps, including donor selection, pancreas processing, pancreas perfusion and digestion, i
228 ve care unit length, amylase concentration), pancreas procurement, isolation procedures (brand and co
229 lying pathology in human as well as rat LADA pancreases provided identical results, allowing the conc
230 deficit should be discussed with prospective pancreas recipients given the potential impact on posttr
232 measurement of the degree of overlap between pancreas regions of interest between the two readers, wa
233 and pSTAT3 in the PanIN lesions of KC mouse pancreas reinforces the crucial involvement of MUC5AC in
234 icient immunosuppression to reliably prevent pancreas rejection in SPK transplants undergoing CNI wit
235 til CNI was withdrawn, with four of the five pancreas rejections occurring during or after CNI withdr
238 ction of insulin-producing beta-cells of the pancreas, resulting in dependence on exogenously adminis
241 ssues that regulate metabolism including the pancreas, skeletal muscle, and adipose tissue, its funct
242 ing tissue-specific RNA-sequencing data from pancreas, small intestine, ovary, kidney, and heart with
243 rson Cancer Center group (MDA) and the Japan Pancreas Society (JPS) have introduced other grading sys
251 s to a pathological process in the endocrine pancreas, suggesting pancreatitis might be a potential p
252 isted for remote IPMNs limited to the dorsal pancreas, suggesting UDD may be associated with an aggre
253 integrated blood flow throughout the entire pancreas suggests direct interactions between islet endo
254 ords: Abdomen/GI, Genetic Defects, Oncology, Pancreas Supplemental material is available for this art
256 uptake of (111)In-anti-gammaH2AX-TAT in the pancreas survive for a significantly shorter time than m
258 iabetes did not significantly correlate with pancreas SUVR-1 (20-30 min) (R (2) = 0.36, P = 0.16).
259 e at diagnosis correlated significantly with pancreas SUVR-1 (20-30 min) (R (2) = 0.67, P = 0.025).
260 Centrally, vagal neurons projecting to the pancreas terminate in the commissural nucleus of the sol
261 ry numbers, but not of perivascular cells in pancreas, testis and thyroid gland, with age in mice and
262 betes includes abnormalities in the exocrine pancreas that may induce endocrine cellular stress as a
263 vation caused a metaplastic phenotype in the pancreas that was missing in mice with acinar-specific p
266 8 children-digest islet equivalents per gram pancreas tissue (IEQ/g) and digest IEQ per kilogram body
267 ation: (a) poor yield of islets from donated pancreas tissue and (b) the need for life-long immunosup
268 s were obtained from multiple centres: Barts Pancreas Tissue Bank, University College London, Univers
271 er from DM links the disease in the exocrine pancreas to a pathological process in the endocrine panc
272 ranges from quasi-experimental work in human pancreas to multiple meta-analyses of Randomized Control
273 steoblast-specific insulin deficiency on the pancreas-to-skeleton-to-pancreas circuit has not been st
279 first case report of simultaneous liver and pancreas transplantation as treatment of WRS in a small
280 ntial for survival of patients with WRS, and pancreas transplantation cures their type I diabetes mel
281 a nonacute, combined, simultaneous liver and pancreas transplantation from a pediatric donor without
283 may be a metabolic consequence of successful pancreas transplantation that results in EW gain in a pr
285 As) are an invaluable resource in kidney and pancreas transplantation when vascular reconstruction is
286 o combat type 1 diabetes (T1D) include donor pancreas transplantation, exogenous insulin administrati
288 se data demonstrate that MRI measurements of pancreas volume between two readers are repeatable and r
292 the Cox regression analysis, bladder drained pancreas was associated with lower probability of prolon
293 biopsy-proven acute rejection (BPAR) of the pancreas was low in both groups until CNI was withdrawn,
294 o mimic the physiological oxygenation of the pancreas, we demonstrate high viability and preserved en
295 To directly assess the role of NKG2D in the pancreas, we generated NOD mice that express an NKG2D li
296 e esophagus, stomach, colorectum, liver, and pancreas were extracted from the GLOBOCAN database for t
298 inuously integrated to those in the exocrine pancreas, which made the islet circulation rather open,
300 ancreases showed differences in areas of the pancreas with respect to immune cell infiltration and a